Barry Herman, MD, MMM

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension (AMPH EROS) in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder

Objective: Determine if AMPH EROS has an onset of effect at 30 minutes post-dose in children with ADHD.

Antonio Pardo , MD;

Barry Herman , MD, MMM;

Ann Childress , MD;

Thomas King , MS, MPH;

11/22/2019

Single-Dose Pharmacokinetics of Amphetamine Extended-Release Tablet (AMPH ER TAB) Compared With Amphetamine Extended-Release Oral Suspension (AMPH EROS)

OBJECTIVES: Evaluate bioavailability of single-dose amphetamine extended-release tablet (AMPH ER TAB) 20 mg, swallowed whole/chewed and amphetamine extended-release oral suspension (AMPH ...

Thomas King , MS, MPH;

Antonio Pardo , MD;

Barry Herman , MD, MMM;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Barry Herman, MD, MMM

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products